Literature DB >> 22607850

A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.

Henry Krum1, Bernd Lemke, David Birnie, Kathy Lai-Fun Lee, Kazutaka Aonuma, Randall C Starling, Maurizio Gasparini, John Gorcsan, Tyson Rogers, Alex Sambelashvili, Amy Kalmes, David Martin.   

Abstract

BACKGROUND: The magnitude of benefit of cardiac resynchronization therapy (CRT) varies significantly among its recipients; approximately 30% of CRT patients do not report clinical improvement. Optimization of CRT pacing parameters can further improve cardiac function, both acutely and chronically. Echocardiographic optimization is used in clinical practice, but it is time and resource consuming. In addition, optimal settings at rest may change later with activity or cardiac remodeling. The adaptive CRT (aCRT) algorithm was designed to provide automatic ambulatory adjustment of CRT pacing configuration (left ventricular or biventricular pacing) and device delays based on periodic measurement of electrical conduction intervals.
METHODS: The aCRT algorithm is currently undergoing evaluation in a prospective, randomized, double-blinded, worldwide clinical trial. The trial enrolled 522 patients, who satisfied standard clinical indications for a CRT device. Within 2 weeks after the implant, the patients were randomized to aCRT versus echo-optimized biventricular pacing (Echo) settings in 2:1 ratio and followed up at 1-, 3-, 6-, and 12-month postrandomization. The noninferiority primary trial objectives at 6-month postrandomization are to demonstrate that (a) the percentage of aCRT patients who improved in their clinical composite score is at least as high as the percentage of Echo patients; (b) cardiac performance as assessed by echocardiography is similar when using aCRT settings versus echo-optimized settings; and (c) aCRT does not result in inappropriate device settings. First and last patient enrollments occurred in November 2009 and December 2010, respectively.
CONCLUSIONS: The safety and efficacy of the aCRT algorithm will be evaluated in this ongoing clinical trial.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22607850     DOI: 10.1016/j.ahj.2012.02.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Clinical Relevance Of Systematic CRT Device Optimization.

Authors:  Maurizio Lunati; Giovanni Magenta; Giuseppe Cattafi; Antonella Moreo; Giacomo Falaschi; Danilo Contardi; Emanuela Locati
Journal:  J Atr Fibrillation       Date:  2014-08-31

Review 2.  Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.

Authors:  Gerasimos Filippatos; David Birnie; Michael R Gold; Bart Gerritse; Ahmad Hersi; Sandra Jacobs; Kengo Kusano; Christophe Leclercq; Wilfried Mullens; Bruce L Wilkoff
Journal:  Eur J Heart Fail       Date:  2017-07       Impact factor: 15.534

3.  Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.

Authors:  Jagmeet P Singh; Yong-Mei Cha; Maurizio Lunati; Eugene S Chung; Shelby Li; Pascal Smeets; David O'Donnell
Journal:  J Cardiovasc Electrophysiol       Date:  2020-02-28

4.  Adaptive Cardiac Resynchronization Therapy Effect on Electrical Dyssynchrony (aCRT-ELSYNC): A randomized controlled trial.

Authors:  Kazi T Haq; Nichole M Rogovoy; Jason A Thomas; Christopher Hamilton; Katherine J Lutz; Ashley Wirth; Aron B Bender; David M German; Ryle Przybylowicz; Peter van Dam; Thomas A Dewland; Khidir Dalouk; Eric Stecker; Babak Nazer; Peter M Jessel; Karen S MacMurdy; Ignatius Gerardo E Zarraga; Bassel Beitinjaneh; Charles A Henrikson; Merritt Raitt; Cristina Fuss; Maros Ferencik; Larisa G Tereshchenko
Journal:  Heart Rhythm O2       Date:  2021-06-29

Review 5.  Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device.

Authors:  Georges E Daoud; Mahmoud Houmsse
Journal:  Med Devices (Auckl)       Date:  2016-01-18

6.  T-wave oversensing due to left ventricle-only pacing in cardiac resynchronization therapy optimization algorithm.

Authors:  Philippe André; Benoit Plourde; Franck Molin; Jean-Francois Sarrazin; Jean Champagne; François Philippon
Journal:  HeartRhythm Case Rep       Date:  2018-06-05

7.  Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response.

Authors:  Ahmed AlTurki; Pedro Y Lima; Martin L Bernier; Daniel Garcia; Alejandro Vidal; Bruno Toscani; Sergio Diaz; Mauricio Montemezzo; Alaa Al-Dossari; Tomy Hadjis; Jacqueline Joza; Vidal Essebag
Journal:  CJC Open       Date:  2020-01-21

8.  Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy.

Authors:  Bruce L Wilkoff; David Birnie; Michael R Gold; Ahmad S Hersi; Sandra Jacobs; Bart Gerritse; Kengo Kusano; Christophe Leclercq; Wilfried Mullens; Gerasimos Filippatos
Journal:  ESC Heart Fail       Date:  2020-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.